Biobrane versus topical agents in the treatment of adult scald burns

Nicco Krezdorn, Sören Könneker, Felix Julian Paprottka, Christian Tapking, Tobias R. Mett, G. Felix Brölsch, Maria Boyce, Ramin Ipaktchi, Peter M. Vogt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Limited data is available for treatment of scald lesions in adults. The use of the biosynthetic matrix Biobrane® has been suggested as treatment option with more benefits over topical dressings. Application of Biobrane® in scalds in our center led to a perceived increase of infection, secondary deepening, surgery and length of stay. We therefore assessed the effect of different treatment options in adult scalds in our center. Methods We performed a retrospective cohort study of adult patients that have been admitted with scalds in our center between 2011 and 2014. We assessed two groups, group 1 with Biobrane® as initial treatment and group 2 with topical treatment using polyhexanid hydrogel and fatty gauze. Primary outcome variables were rate of secondary deepening, surgery, infection (defined as positive microbiological swabs and antibiotic treatment) and length of stay. Total body surface area (TBSA) as well as diabetes mellitus (DM), hypertension, smoking and alcohol consumption as potential confounders were included. Results A total of 52 patients were included in this study. 36 patients received treatment with Biobrane® and 16 with ointment and fatty gauze. No significant differences were found for age and TBSA whereas gender ratio was different (25/11 male/female in group 1 vs 4/12 in group 2, p = 0.003). Rate of secondary deepening, surgery, infection as well as days of hospital stay (DOHS) were comparable. Logistic and multilinear regression showed TBSA to be a predictive factor for infection (p = 0.041), and TBSA and age for length of stay (age p = 0.036; TBSA p = 0.042) in group 1. Conclusion The use of Biobrane® in adult scald lesions is safe and non-inferior to topical treatment options. In elder patients and larger TBSA Biobrane® may increase the risk of infection or a prolonged stay in hospital. Level of evidence Level 3 – retrospective cohort study.

Original languageEnglish (US)
Pages (from-to)195-199
Number of pages5
JournalBurns
Volume43
Issue number1
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

Fingerprint

Burns
Body Surface Area
Length of Stay
Therapeutics
Infection
Cohort Studies
Retrospective Studies
Biobrane
Hydrogel
Bandages
Ointments
Coinfection
Alcohol Drinking
Diabetes Mellitus
Logistic Models
Smoking
Anti-Bacterial Agents
Hypertension

Keywords

  • Adult scald
  • Biobrane
  • Burn wound infection
  • Scald lesion
  • Scald treatment

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Krezdorn, N., Könneker, S., Paprottka, F. J., Tapking, C., Mett, T. R., Brölsch, G. F., ... Vogt, P. M. (2017). Biobrane versus topical agents in the treatment of adult scald burns. Burns, 43(1), 195-199. https://doi.org/10.1016/j.burns.2016.07.022

Biobrane versus topical agents in the treatment of adult scald burns. / Krezdorn, Nicco; Könneker, Sören; Paprottka, Felix Julian; Tapking, Christian; Mett, Tobias R.; Brölsch, G. Felix; Boyce, Maria; Ipaktchi, Ramin; Vogt, Peter M.

In: Burns, Vol. 43, No. 1, 01.02.2017, p. 195-199.

Research output: Contribution to journalArticle

Krezdorn, N, Könneker, S, Paprottka, FJ, Tapking, C, Mett, TR, Brölsch, GF, Boyce, M, Ipaktchi, R & Vogt, PM 2017, 'Biobrane versus topical agents in the treatment of adult scald burns', Burns, vol. 43, no. 1, pp. 195-199. https://doi.org/10.1016/j.burns.2016.07.022
Krezdorn N, Könneker S, Paprottka FJ, Tapking C, Mett TR, Brölsch GF et al. Biobrane versus topical agents in the treatment of adult scald burns. Burns. 2017 Feb 1;43(1):195-199. https://doi.org/10.1016/j.burns.2016.07.022
Krezdorn, Nicco ; Könneker, Sören ; Paprottka, Felix Julian ; Tapking, Christian ; Mett, Tobias R. ; Brölsch, G. Felix ; Boyce, Maria ; Ipaktchi, Ramin ; Vogt, Peter M. / Biobrane versus topical agents in the treatment of adult scald burns. In: Burns. 2017 ; Vol. 43, No. 1. pp. 195-199.
@article{e94c4f0f38bc4e70bb302fbf33d0eb1f,
title = "Biobrane versus topical agents in the treatment of adult scald burns",
abstract = "Background Limited data is available for treatment of scald lesions in adults. The use of the biosynthetic matrix Biobrane{\circledR} has been suggested as treatment option with more benefits over topical dressings. Application of Biobrane{\circledR} in scalds in our center led to a perceived increase of infection, secondary deepening, surgery and length of stay. We therefore assessed the effect of different treatment options in adult scalds in our center. Methods We performed a retrospective cohort study of adult patients that have been admitted with scalds in our center between 2011 and 2014. We assessed two groups, group 1 with Biobrane{\circledR} as initial treatment and group 2 with topical treatment using polyhexanid hydrogel and fatty gauze. Primary outcome variables were rate of secondary deepening, surgery, infection (defined as positive microbiological swabs and antibiotic treatment) and length of stay. Total body surface area (TBSA) as well as diabetes mellitus (DM), hypertension, smoking and alcohol consumption as potential confounders were included. Results A total of 52 patients were included in this study. 36 patients received treatment with Biobrane{\circledR} and 16 with ointment and fatty gauze. No significant differences were found for age and TBSA whereas gender ratio was different (25/11 male/female in group 1 vs 4/12 in group 2, p = 0.003). Rate of secondary deepening, surgery, infection as well as days of hospital stay (DOHS) were comparable. Logistic and multilinear regression showed TBSA to be a predictive factor for infection (p = 0.041), and TBSA and age for length of stay (age p = 0.036; TBSA p = 0.042) in group 1. Conclusion The use of Biobrane{\circledR} in adult scald lesions is safe and non-inferior to topical treatment options. In elder patients and larger TBSA Biobrane{\circledR} may increase the risk of infection or a prolonged stay in hospital. Level of evidence Level 3 – retrospective cohort study.",
keywords = "Adult scald, Biobrane, Burn wound infection, Scald lesion, Scald treatment",
author = "Nicco Krezdorn and S{\"o}ren K{\"o}nneker and Paprottka, {Felix Julian} and Christian Tapking and Mett, {Tobias R.} and Br{\"o}lsch, {G. Felix} and Maria Boyce and Ramin Ipaktchi and Vogt, {Peter M.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.burns.2016.07.022",
language = "English (US)",
volume = "43",
pages = "195--199",
journal = "Burns",
issn = "0305-4179",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Biobrane versus topical agents in the treatment of adult scald burns

AU - Krezdorn, Nicco

AU - Könneker, Sören

AU - Paprottka, Felix Julian

AU - Tapking, Christian

AU - Mett, Tobias R.

AU - Brölsch, G. Felix

AU - Boyce, Maria

AU - Ipaktchi, Ramin

AU - Vogt, Peter M.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background Limited data is available for treatment of scald lesions in adults. The use of the biosynthetic matrix Biobrane® has been suggested as treatment option with more benefits over topical dressings. Application of Biobrane® in scalds in our center led to a perceived increase of infection, secondary deepening, surgery and length of stay. We therefore assessed the effect of different treatment options in adult scalds in our center. Methods We performed a retrospective cohort study of adult patients that have been admitted with scalds in our center between 2011 and 2014. We assessed two groups, group 1 with Biobrane® as initial treatment and group 2 with topical treatment using polyhexanid hydrogel and fatty gauze. Primary outcome variables were rate of secondary deepening, surgery, infection (defined as positive microbiological swabs and antibiotic treatment) and length of stay. Total body surface area (TBSA) as well as diabetes mellitus (DM), hypertension, smoking and alcohol consumption as potential confounders were included. Results A total of 52 patients were included in this study. 36 patients received treatment with Biobrane® and 16 with ointment and fatty gauze. No significant differences were found for age and TBSA whereas gender ratio was different (25/11 male/female in group 1 vs 4/12 in group 2, p = 0.003). Rate of secondary deepening, surgery, infection as well as days of hospital stay (DOHS) were comparable. Logistic and multilinear regression showed TBSA to be a predictive factor for infection (p = 0.041), and TBSA and age for length of stay (age p = 0.036; TBSA p = 0.042) in group 1. Conclusion The use of Biobrane® in adult scald lesions is safe and non-inferior to topical treatment options. In elder patients and larger TBSA Biobrane® may increase the risk of infection or a prolonged stay in hospital. Level of evidence Level 3 – retrospective cohort study.

AB - Background Limited data is available for treatment of scald lesions in adults. The use of the biosynthetic matrix Biobrane® has been suggested as treatment option with more benefits over topical dressings. Application of Biobrane® in scalds in our center led to a perceived increase of infection, secondary deepening, surgery and length of stay. We therefore assessed the effect of different treatment options in adult scalds in our center. Methods We performed a retrospective cohort study of adult patients that have been admitted with scalds in our center between 2011 and 2014. We assessed two groups, group 1 with Biobrane® as initial treatment and group 2 with topical treatment using polyhexanid hydrogel and fatty gauze. Primary outcome variables were rate of secondary deepening, surgery, infection (defined as positive microbiological swabs and antibiotic treatment) and length of stay. Total body surface area (TBSA) as well as diabetes mellitus (DM), hypertension, smoking and alcohol consumption as potential confounders were included. Results A total of 52 patients were included in this study. 36 patients received treatment with Biobrane® and 16 with ointment and fatty gauze. No significant differences were found for age and TBSA whereas gender ratio was different (25/11 male/female in group 1 vs 4/12 in group 2, p = 0.003). Rate of secondary deepening, surgery, infection as well as days of hospital stay (DOHS) were comparable. Logistic and multilinear regression showed TBSA to be a predictive factor for infection (p = 0.041), and TBSA and age for length of stay (age p = 0.036; TBSA p = 0.042) in group 1. Conclusion The use of Biobrane® in adult scald lesions is safe and non-inferior to topical treatment options. In elder patients and larger TBSA Biobrane® may increase the risk of infection or a prolonged stay in hospital. Level of evidence Level 3 – retrospective cohort study.

KW - Adult scald

KW - Biobrane

KW - Burn wound infection

KW - Scald lesion

KW - Scald treatment

UR - http://www.scopus.com/inward/record.url?scp=84992702813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992702813&partnerID=8YFLogxK

U2 - 10.1016/j.burns.2016.07.022

DO - 10.1016/j.burns.2016.07.022

M3 - Article

C2 - 27507189

AN - SCOPUS:84992702813

VL - 43

SP - 195

EP - 199

JO - Burns

JF - Burns

SN - 0305-4179

IS - 1

ER -